<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes - Health AI Hub</title>
    <meta name="description" content="This pilot study introduces a fully automated deep learning-based approach for opportunistic screening of Type 2 Diabetes Mellitus (T2DM) using CT imaging bioma">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10484v1" target="_blank">2511.10484v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-13
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Tejas Sudharshan Mathai, Anisa V. Prasad, Xinya Wang, Praveen T. S. Balamuralikrishna, Yan Zhuang, Abhinav Suri, Jianfei Liu, Perry J. Pickhardt, Ronald M. Summers
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10484v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10484v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This pilot study introduces a fully automated deep learning-based approach for opportunistic screening of Type 2 Diabetes Mellitus (T2DM) using CT imaging biomarkers, specifically pancreatic surface lobularity (PSL). It found that diabetic patients exhibit significantly higher PSL compared to non-diabetic individuals, and a multivariate model incorporating these CT biomarkers achieved high accuracy in T2DM prediction. The findings suggest PSL is a useful biomarker for early T2DM detection.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research provides a non-invasive, automated method for opportunistic screening of T2DM using routinely acquired CT scans, offering a novel pathway for earlier detection and intervention before the progression of severe pancreatic dysfunction and organ damage. It transforms existing imaging data into actionable insights for metabolic disease.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes the development and application of deep learning models for automated segmentation of the pancreas from CT scans and the derivation of quantitative imaging biomarkers (specifically, pancreas surface lobularity). This AI-driven approach is used to create an opportunistic screening tool for Type 2 Diabetes Mellitus, aiming to improve early detection and prediction of the disease.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Type 2 Diabetes Mellitus (T2DM) is associated with morphological changes and increased ectopic fat in the pancreas; however, the role of pancreas surface lobularity (PSL) as a biomarker has been under-investigated.</li>
                    
                    <li>A fully automated deep learning methodology was developed to delineate the pancreas and other abdominal structures from CT scans for biomarker derivation.</li>
                    
                    <li>Four deep learning models were evaluated for pancreas segmentation, with the PancAP model achieving the highest Dice score (0.79 ¬± 0.17) and lowest Average Symmetric Surface Distance (ASSD) error (1.94 ¬± 2.63 mm) (p<0.05).</li>
                    
                    <li>Automated detection of PSL revealed significantly higher values in diabetic patients (4.26 ¬± 8.32) compared to non-diabetic patients (3.19 ¬± 3.62) (p=0.01).</li>
                    
                    <li>A multivariate model trained with CT biomarkers achieved robust performance for predicting T2DM, with an Area Under the Curve (AUC) of 0.90, 66.7% sensitivity, and 91.9% specificity.</li>
                    
                    <li>The study demonstrates that PSL is a useful CT biomarker for T2DM screening, offering potential for opportunistic detection.</li>
                    
                    <li>The proposed approach could potentially aid in predicting the early onset of T2DM, allowing for timely intervention.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized a fully automated, deep learning-based approach to analyze abdominal CT scans. Four distinct deep learning models were trained to segment the pancreas from a dataset of 584 patients. Following segmentation, pancreas surface lobularity (PSL) was automatically detected and quantified as an imaging biomarker. A multivariate predictive model, incorporating PSL and potentially other derived CT biomarkers, was then developed to classify patients as diabetic or non-diabetic.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Pancreas Surface Lobularity (PSL) was found to be significantly higher in diabetic patients (mean 4.26 ¬± 8.32) compared to non-diabetic patients (mean 3.19 ¬± 3.62, p=0.01). The PancAP deep learning model achieved the best pancreas segmentation performance with a Dice score of 0.79 ¬± 0.17 and an Average Symmetric Surface Distance (ASSD) of 1.94 ¬± 2.63 mm (p<0.05). The multivariate model, leveraging CT biomarkers, demonstrated strong predictive capabilities for T2DM with an AUC of 0.90, a sensitivity of 66.7%, and a specificity of 91.9%.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The development of an automated CT-based biomarker like PSL could enable opportunistic screening for T2DM during routine CT scans ordered for other medical conditions. This facilitates the early identification of individuals with undiagnosed diabetes or those at high risk, allowing for timely lifestyle interventions, medical management, and potentially preventing or delaying the onset of T2DM complications, thus improving patient outcomes and reducing healthcare burdens.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract explicitly states this is 'pilot work,' indicating that the findings are preliminary and may require validation in larger, more diverse cohorts to confirm generalizability and robustness. The specific composition and number of 'other CT biomarkers' in the multivariate model are not detailed.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The study suggests that the derived CT biomarkers, particularly PSL, could potentially help predict the early onset of T2DM. Future research could involve longitudinal studies to assess the predictive power of PSL in identifying pre-diabetes or progression to T2DM, further validation in diverse populations, and integration into comprehensive risk assessment tools.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Endocrinology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Preventive Medicine</span>
                    
                    <span class="tag">Metabolic Disease</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Pancreas Surface Lobularity</span>
                    
                    <span class="tag tag-keyword">Type 2 Diabetes Mellitus</span>
                    
                    <span class="tag tag-keyword">CT Biomarker</span>
                    
                    <span class="tag tag-keyword">Opportunistic Screening</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Pancreas Segmentation</span>
                    
                    <span class="tag tag-keyword">Computer Vision</span>
                    
                    <span class="tag tag-keyword">Early Detection</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease that affects millions of people worldwide. Early detection is crucial as it can alter pancreas function through morphological changes and increased deposition of ectopic fat, eventually leading to organ damage. While studies have shown an association between T2DM and pancreas volume and fat content, the role of increased pancreatic surface lobularity (PSL) in patients with T2DM has not been fully investigated. In this pilot work, we propose a fully automated approach to delineate the pancreas and other abdominal structures, derive CT imaging biomarkers, and opportunistically screen for T2DM. Four deep learning-based models were used to segment the pancreas in an internal dataset of 584 patients (297 males, 437 non-diabetic, age: 45$\pm$15 years). PSL was automatically detected and it was higher for diabetic patients (p=0.01) at 4.26 $\pm$ 8.32 compared to 3.19 $\pm$ 3.62 for non-diabetic patients. The PancAP model achieved the highest Dice score of 0.79 $\pm$ 0.17 and lowest ASSD error of 1.94 $\pm$ 2.63 mm (p$<$0.05). For predicting T2DM, a multivariate model trained with CT biomarkers attained 0.90 AUC, 66.7\% sensitivity, and 91.9\% specificity. Our results suggest that PSL is useful for T2DM screening and could potentially help predict the early onset of T2DM.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Submitted to IEEE ISBI 2026</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>